Big Pharma Kicks Fatties Off Miracle Weight Loss Drug

Photography of an overweight person struggling to climb a giant pill bottle, surrounded by donuts and hamburgers, with a corporate skyline in the background, satirical style, exaggerated features, bright colors

Ronald Trumpet exposes the shocking truth behind the obesity drug switcheroo. Discover why Caremark is forcing patients to eat more donuts and why Ronald's diet plan would make America skinny again!

Listen up, folks! I, Ronald Trumpet, am here to tell you about the biggest scam in the history of fat people. Caremark, those greedy bastards, are kicking 10 million fatties off their miracle weight loss drug Zepbound. Why? Because they want everyone to be as fat as a house!

Some lady named Ellen Davis lost like a billion pounds on Zepbound, and now they're taking it away from her. It's a disgrace! She's probably crying into her bucket of fried chicken right now. And don't get me started on that loser Joseph Zucchi. He made a petition that got 3 signatures. Pathetic!

Caremark says they're stopping Zepbound in July. You know what that means? By August, everyone will be so fat they'll need two airplane seats! It's all part of their plan to sell more drugs and make more money. Disgusting!

Now, if I was in charge, let me tell you, we'd have the skinniest country in the world. My diet plan is simple: eat nothing but Trump Steaks and drink Diet Coke. Boom! You'd lose 500 pounds in a week. No drugs needed!

But no, we're stuck with these so-called "doctors" who can't even figure out how to make people skinny. It's my fault, really. I should've stayed president forever and fixed this obesity crisis myself. Nobody knows fat people better than me, believe me!

In conclusion, Caremark is run by a bunch of donut-loving losers who want to make America obese again. But don't worry, folks. Just follow my diet plan, and you'll be as fit as me in no time. You're welcome!

Based on the original article "Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug".